Meco`s Masterfit System Selected for Nexus Pharmaceutical Facility

Introduction
“Our priority is to provide our customers with the high purity water and steam that is critical to the development and manufacturing of life-saving medications now and for future generations.” —George Gsell, MECO President

Nexus Pharmaceuticals, maker of difficult-to-manufacture, high quality, FDA-approved specialty and generic drugs, is opening a $250 million, U.S. based pharmaceutical manufacturing facility in Pleasant Prairie, WI. The company, which specializes in making critical-need injectable medications more available, partnered with MECO, choosing the MASTERfit water purification system for its pharmaceutical production.

The Nexus manufacturing facility is the only project of its kind in the sterile generic injectables industry in the last 30 years. Construction began in 2019 for the new manufacturing facility, and a Phase One completion is expected in 2021. Once approved by the Food and Drug Administration (FDA), commercial production is expected to commence in 2022.

Nexus and MECO are building a better tomorrow, with tomorrow’s water.